A detailed history of Bank Of America Corp transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Bank Of America Corp holds 586,464 shares of PRCT stock, worth $57.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
586,464
Previous 647,215 9.39%
Holding current value
$57.1 Million
Previous $39.5 Million 18.82%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$56.31 - $84.99 $3.42 Million - $5.16 Million
-60,751 Reduced 9.39%
586,464 $47 Million
Q2 2024

Aug 14, 2024

BUY
$45.73 - $69.19 $19 Million - $28.8 Million
415,599 Added 179.43%
647,215 $39.5 Million
Q1 2024

May 15, 2024

BUY
$40.38 - $50.75 $5.92 Million - $7.45 Million
146,727 Added 172.85%
231,616 $11.4 Million
Q4 2023

Feb 14, 2024

BUY
$24.89 - $43.41 $491,652 - $857,477
19,753 Added 30.33%
84,889 $3.56 Million
Q2 2023

Aug 14, 2023

SELL
$26.7 - $37.02 $358,020 - $496,401
-13,409 Reduced 17.07%
65,136 $2.3 Million
Q1 2023

May 12, 2023

SELL
$26.64 - $39.74 $4.96 Million - $7.4 Million
-186,136 Reduced 70.32%
78,545 $2.23 Million
Q4 2022

Feb 10, 2023

SELL
$38.78 - $46.78 $339,674 - $409,746
-8,759 Reduced 3.2%
264,681 $11 Million
Q3 2022

Nov 14, 2022

BUY
$30.9 - $50.65 $7.62 Million - $12.5 Million
246,445 Added 912.93%
273,440 $11.3 Million
Q2 2022

Aug 12, 2022

BUY
$29.23 - $44.45 $337,431 - $513,130
11,544 Added 74.71%
26,995 $882,000
Q1 2022

May 16, 2022

SELL
$16.89 - $35.74 $53,304 - $112,795
-3,156 Reduced 16.96%
15,451 $540,000
Q4 2021

Feb 08, 2022

BUY
$24.6 - $46.29 $449,614 - $846,042
18,277 Added 5538.48%
18,607 $465,000
Q3 2021

Nov 15, 2021

BUY
$35.91 - $41.94 $11,850 - $13,840
330 New
330 $13,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $4.34B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.